Suppr超能文献

联合米卡芬净和伊曲康唑治疗成功治愈两例肺曲霉病

[Two cases of pulmonary aspergillosis successfully treated with combinated micafungin and itraconazole therapy].

作者信息

Furugen Makoto, Haranaga Shusaku, Touyama Masato, Shiroma Runa, Yara Satomi, Shinzato Takashi, Higa Futoshi, Tateyama Masao, Saitou Atsushi, Fujita Jiro

机构信息

Department of Medicine and Infectious Diseases, Graduate School of Medicine, University of the Ryukyus.

出版信息

Kansenshogaku Zasshi. 2005 Dec;79(12):951-6. doi: 10.11150/kansenshogakuzasshi1970.79.951.

Abstract

We report 2 cases of pulmonary aspergillosis treated successfully by combining micafungin and traconazole. Case 1: A 51-year-old man with hemoptysis and dyspnea on effort treated for pulmonary tuberculosis and aspergillosis was found on chest CT on admission to have a fungus ball in the left upper lobe and increasing consolidation around the cavity of both lung fields. Bronchoscopy proved positive for aspergillus PCR in bronchial lavage. He was diagnosed with chronic necrotizing pulmonary aspergillosis, based on clinical and radiological findings and the positive reaction for aspergillus PCR. He was treated with micafungin alone at first, this proved ineffective, so itraconazole was added, resulting in improvement. Case 2: A 24-year-old woman with stabilized Hodgkin's disease (mixed). She had suffered from a cough and back pain, and chest CT showed increasing consolidation inside and around a giant bulla. She was diagnosed with chronic necrotizing pulmonary aspergillosis, based on isolation for Aspergillus sp. in sputum culture and a positive reaction for Aspergillus antigen in bronchial lavage and Aspergillus antibody in serum. She was treated with the combined micafungin and itraconazole, which rapidly improved symptoms and radiological findings. Pulmonary aspergillosis therapy is often difficult, because delivery of the drug to the infection site is limited and drug tolerance is poor. We found that combination micafungin and itraconazole therapy is tolerable and effective in these cases.

摘要

我们报告了2例通过联合使用米卡芬净和itraconazole成功治疗的肺曲霉病病例。病例1:一名51岁男性,因咯血和劳力性呼吸困难接受肺结核和曲霉病治疗,入院时胸部CT发现左上叶有一个真菌球,双肺野空洞周围实变增加。支气管镜检查显示支气管灌洗曲霉PCR呈阳性。根据临床和影像学表现以及曲霉PCR阳性反应,他被诊断为慢性坏死性肺曲霉病。起初单独用米卡芬净治疗,结果无效,因此加用itraconazole,病情得到改善。病例2:一名24岁患有稳定期霍奇金病(混合型)的女性。她有咳嗽和背痛症状,胸部CT显示巨大肺大疱内及周围实变增加。根据痰培养分离出曲霉属、支气管灌洗曲霉抗原阳性和血清曲霉抗体阳性反应,她被诊断为慢性坏死性肺曲霉病。她接受了米卡芬净和itraconazole联合治疗,症状和影像学表现迅速改善。肺曲霉病的治疗通常很困难,因为药物输送到感染部位受限且药物耐受性差。我们发现在这些病例中,米卡芬净和itraconazole联合治疗耐受性良好且有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验